Mostrando 2 resultados de: 2
Nimotuzumab in combination with radiotherapy in high grade glioma patients: A single institution experience
ArticleAbstract: Nimotuzumab, a humanized antibody targeting epidermal growth factor receptor, has potent anti-prolifPalabras claves:Anaplastic astrocytoma, glioblastoma multiforme, High grade glioma, Monoclonal antibody, nimotuzumab, RadiotherapyAutores:Alert J., Chon I., Jorrín E., Luaces P.L.o., Marinello J.J.u., Miranda N., Solomón M.T.e., Tania CrombetFuentes:scopusRadiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial
ArticleAbstract: BACKGROUND: The prognosis of patients bearing high grade glioma remains dismal. Epidermal Growth FacPalabras claves:Autores:Alert J., Bach F., Ballesteros J., Catala M., de-Castro N., Domíngez R., Figueredo J., Griego M.G.o., Luaces P.L.o., Marinello J.J.u., Martell J.A.n., Quintanal N., Salva S., Selva J.C.é., Solomón M.T.e., Tania Crombet, Toledo C., Vaquer J.Fuentes:scopus